転移性がん治療市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00017819
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Metastatic Cancer Treatment Market Updates by 2031

Buy Now

市場紹介 体の離れた部分に広がるがんは転移がんと呼ばれます。いくつかの種類のがんでは、ステージ IV のがんとも呼ばれます。がん細胞が体のさまざまな部分に広がるプロセスを転移と呼びます。転移がんは原発がんと同じ名前を持ちます。たとえば、肺にまで増殖した乳がんは、肺がんではなく転移性乳がんと呼ばれます。 市場のダイナミクス この病気の影響を受ける患者の医療ニーズの増加、乳がんの発生率の増加、およびその一貫した再発が市場の成長を推進しています。さらに、テクノロジーの進歩と国民の意識の高まりも市場の需要に影響を与えています。しかし、転移性疾患に対する効果的な治療法の欠如と重篤な副作用が市場の成長を妨げています。 市場範囲 「2031 年までの転移がん治療市場分析」は、世界市場動向分析に特に焦点を当てたヘルスケア業界の専門的で詳細な調査です。このレポートは、治療適応および製品ごとに詳細な市場分割を行い、転移がん治療市場の概要を提供することを目的としています。転移がん治療市場は、予測期間中に高い成長を遂げると予想されます。このレポートは、転移がん治療市場の主要企業の市場状況に関する主要な統計を提供し、市場の主要な傾向と機会を提供します。 市場セグメンテーション 転移がん治療市場は、治療適応と製品に基づいて分割されています。治療適応に基づいて、市場は乳がん、前立腺がん、肺がん、黒色腫、結腸直腸がんなどに分類されます。市場は製品ごとにブランド医薬品とジェネリック医薬品に分類されます。

Metastatic Cancer Treatment Market: Strategic Insights

Metastatic Cancer Treatment Market
  • CAGR
    CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • HOFFMANN LA ROCHE LTD
  • NOVARTIS AG
  • MERCK
  • ELI LILLY AND COMPANY
  • JOHNSON AND JOHNSON
  • PFIZER
  • ASTRAZENECA
  • GLAXOSMITHKLINE
  • SUN PHARMACEUTICAL

Regional Overview

Regional And Country Scope
  • 北米(米国,カナダ,メキシコ)
  • ヨーロッパ(英国,ドイツ,フランス,ロシア,イタリア,その他のヨーロッパ)
  • アジア太平洋(中国,インド,日本,オーストラリア,その他のアジア太平洋)
  • 南米および中米(ブラジル,アルゼンチン,その他の中南米)
  • 中東およびアフリカ(南アフリカ,サウジアラビア,UAE,その他の中東およびアフリカ)

Market Segmentation

Segment 1治療適応(乳がん,前立腺がん,肺がん,黒色腫,結腸直腸がん,その他)
    Segment2製品(ブランド医薬品,ジェネリック医薬品)
      Segment3地理
      • 北アメリカ
      • ヨーロッパ
      • アジア太平洋
      • 南アメリカ
      • 中央アメリカ
      このレポートは、定性的情報と定量的情報の両方を含む業界の詳細な概要を提供します。さまざまなセグメントに基づいた転移がん治療市場の概要と予測を提供します。また、次の 5 つの主要地域に関して、2021 年から 2031 年までの市場規模と予測推定値も提供します。北米、ヨーロッパ、アジア太平洋 (APAC)、中東およびアフリカ (MEA)、中南米。各地域別の転移がん治療市場は、その後、それぞれの国とセグメントごとにサブセグメント化されます。このレポートは、世界 18 か国の分析と予測、およびこの地域に広がる現在の傾向と機会をカバーしています。レポートは、転移がん治療市場に影響を与える需要と供給の両方の要因を分析し、予測期間中に市場に影響を与える市場ダイナミクス、つまり推進力、制約、機会、将来の傾向をさらに評価します。このレポートは、5 つの地域すべてに対する徹底的な PEST 分析も提供します。北米、ヨーロッパ、APAC、MEA、中南米では、これらの地域の転移がん治療市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後。 市場関係者 このレポートでは、有機的および無機的な成長戦略として、転移がん治療市場の主要な発展について取り上げています。さまざまな企業が、製品の発売、製品の承認、特許やイベントなどの有機的な成長戦略に焦点を当てています。市場で目撃された無機質な成長戦略は、買収、パートナーシップとコラボレーションでした。これらの活動により、市場プレーヤーのビジネスと顧客ベースの拡大への道が開かれました。転移がん治療市場の市場プレーヤーは、世界市場での転移がん治療の需要の高まりに伴い、将来的に有利な成長の機会があると予想されています。以下は、転移がん治療市場に従事する数社のリストです。レポートには、転移がん治療市場の主要企業のプロフィールとSWOT分析および市場戦略も含まれています。さらに、このレポートは、企業概要、提供されるコンポーネントとサービス、過去 3 年間の財務情報、過去 5 年間の主な開発などの情報を含む業界の主要企業に焦点を当てています。
        • HOFFMANN-LA ROCHE LTD • NOVARTIS AG • メルク • ELI LILLY AND COMPANY • ジョンソン アンド ジョンソン • ファイザー • アストラゼネカ • グラクソスミスクライン • サンファーマシューティカル• BAYER
      Insight Partner の専任の調査分析チームは、高度な統計専門知識を持つ経験豊富な専門家で構成されており、既存の調査にさまざまなカスタマイズ オプションを提供しています。

      Metastatic Cancer Treatment Market Report Scope

      Report Attribute Details
      Market size in US$ XX million
      Market Size by US$ XX Million
      Global CAGR XX%
      Historical Data 2021-2022
      Forecast period 2024-2031
      Segments Covered By 治療適応(乳がん,前立腺がん,肺がん,黒色腫,結腸直腸がん,その他)
      By 製品(ブランド医薬品,ジェネリック医薬品)
      By 地理
      • 北アメリカ
      • ヨーロッパ
      • アジア太平洋
      • 南アメリカ
      • 中央アメリカ
      Regions and Countries Covered 北米(米国,カナダ,メキシコ)
      • 北米(米国
      • カナダ
      • メキシコ)
      ヨーロッパ(英国,ドイツ,フランス,ロシア,イタリア,その他のヨーロッパ)
      • ヨーロッパ(英国
      • ドイツ
      • フランス
      • ロシア
      • イタリア
      • その他のヨーロッパ)
      アジア太平洋(中国,インド,日本,オーストラリア,その他のアジア太平洋)
      • アジア太平洋(中国
      • インド
      • 日本
      • オーストラリア
      • その他のアジア太平洋)
      南米および中米(ブラジル,アルゼンチン,その他の中南米)
      • 南米および中米(ブラジル
      • アルゼンチン
      • その他の中南米)
      中東およびアフリカ(南アフリカ,サウジアラビア,UAE,その他の中東およびアフリカ)
      • 中東およびアフリカ(南アフリカ
      • サウジアラビア
      • UAE
      • その他の中東およびアフリカ)
      Market leaders and key company profiles
    • HOFFMANN LA ROCHE LTD
    • NOVARTIS AG
    • MERCK
    • ELI LILLY AND COMPANY
    • JOHNSON AND JOHNSON
    • PFIZER
    • ASTRAZENECA
    • GLAXOSMITHKLINE
    • SUN PHARMACEUTICAL
    • Report Coverage
      Report Coverage

      Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

      Segment Covered
      Segment Covered

      This text is related
      to segments covered.

      Regional Scope
      Regional Scope

      North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

      Country Scope
      Country Scope

      This text is related
      to country scope.

      1. HOFFMANN-LA ROCHE LTD
      2. NOVARTIS AG
      3. MERCK
      4. ELI LILLY AND COMPANY
      5. JOHNSON AND JOHNSON
      6. PFIZER
      7. ASTRAZENECA
      8. GLAXOSMITHKLINE
      9. SUN PHARMACEUTICAL
      10. BAYER

      The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

      1. Data Collection and Secondary Research:

      As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

      Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

      1. Primary Research:

      The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

      For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

      A typical research interview fulfils the following functions:

      • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
      • Validates and strengthens in-house secondary research findings
      • Develops the analysis team’s expertise and market understanding

      Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

      • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
      • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

      Below is the breakup of our primary respondents by company, designation, and region:

      Research Methodology

      Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

      1. Data Analysis:

      Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

      • Macro-Economic Factor Analysis:

      We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

      • Country Level Data:

      Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

      • Company Profile:

      The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

      • Developing Base Number:

      Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

      1. Data Triangulation and Final Review:

      The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

      We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

      We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

      Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

      Trends and growth analysis reports related to Medical Device : READ MORE..